Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    TherapeuticsMD Inc.

    NASDAQ: TXMD · Real-Time Price · USD
    1.12
    -0.05 (-4.27%)
    At close: Jun 16, 2025, 3:59 PM
    1.10
    -1.96%
    Pre-market: Jun 17, 2025, 08:33 AM EDT

    TherapeuticsMD Statistics

    Share Statistics

    TherapeuticsMD has 11.57M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 11.57M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 30.6%

    Shares Floating

    n/a
    		 11.34M

    Failed to Deliver (FTD) Shares

    n/a
    		 454

    FTD / Avg. Volume

    n/a
    		 0.89%

    Short Selling Information

    The latest short interest is 83.86K, so 0.72% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 83.86K

    Short % of Shares Out

    n/a
    		 0.72%

    Short % of Float

    n/a
    		 0.99%

    Short Ratio (days to cover)

    n/a
    		 3.64

    Valuation Ratios

    The PE ratio is -4.55 and the forward PE ratio is 6.94. TherapeuticsMD's PEG ratio is 0.07.

    PE Ratio

    n/a
    		 -4.55

    Forward PE

    n/a
    		 6.94

    PS Ratio

    n/a
    		 5.63

    Forward PS

    n/a
    		 1.4

    PB Ratio

    n/a
    		 0.36

    P/FCF Ratio

    n/a
    		 8.48

    PEG Ratio

    n/a
    		 0.07
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for TherapeuticsMD.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.37, with a Debt / Equity ratio of 0.26.

    Current Ratio

    n/a
    		 2.37

    Quick Ratio

    n/a
    		 2.37

    Debt / Equity

    n/a
    		 0.26

    Debt / EBITDA

    n/a
    		 -3.91

    Debt / FCF

    n/a
    		 6.13

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $1,761,000

    Profits Per Employee

    n/a
    		 $-2,181,000

    Employee Count

    n/a
    		 1

    Asset Turnover

    n/a
    		 0.05

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -31K

    Effective Tax Rate

    n/a
    		 1.32%

    Stock Price Statistics

    The stock price has increased by -43.72% in the last 52 weeks. The beta is 0.64, so TherapeuticsMD's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.64

    52-Week Price Change

    n/a
    		 -43.72%

    50-Day Moving Average

    n/a
    		 1.24

    200-Day Moving Average

    n/a
    		 1.27

    Relative Strength Index (RSI)

    n/a
    		 35.56

    Average Volume (20 Days)

    n/a
    		 51,115

    Income Statement

    In the last 12 months, TherapeuticsMD had revenue of 1.76M and earned -2.18M in profits. Earnings per share was -0.19.

    Revenue

    n/a
    		 1.76M

    Gross Profit

    n/a
    		 1.25M

    Operating Income

    n/a
    		 -4.76M

    Net Income

    n/a
    		 -2.18M

    EBITDA

    n/a
    		 -1.83M

    EBIT

    n/a
    		 -3.49M

    Earnings Per Share (EPS)

    n/a
    		 -0.19
    Full Income Statement

    Balance Sheet

    The company has 5.06M in cash and 7.17M in debt, giving a net cash position of -2.12M.

    Cash & Cash Equivalents

    n/a
    		 5.06M

    Total Debt

    n/a
    		 7.17M

    Net Cash

    n/a
    		 -2.12M

    Retained Earnings

    n/a
    		 -951.82M

    Total Assets

    n/a
    		 38.24M

    Working Capital

    n/a
    		 7.77M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 1.17M and capital expenditures 0, giving a free cash flow of 1.17M.

    Operating Cash Flow

    n/a
    		 1.17M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 1.17M

    FCF Per Share

    n/a
    		 0.1
    Full Cash Flow Statement

    Margins

    Gross margin is 71.1%, with operating and profit margins of -270.3% and -123.85%.

    Gross Margin

    n/a
    		 71.1%

    Operating Margin

    n/a
    		 -270.3%

    Pretax Margin

    n/a
    		 -133.05%

    Profit Margin

    n/a
    		 -123.85%

    EBITDA Margin

    n/a
    		 -104.15%

    EBIT Margin

    n/a
    		 -270.3%

    FCF Margin

    n/a
    		 66.44%

    Dividends & Yields

    TXMD does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for TXMD.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on May 9, 2022. It was a backward split with a ratio of 1:50.

    Last Split Date

    n/a
    		 May 9, 2022

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:50

    Scores

    Altman Z-Score

    n/a
    		 -33.99

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist